Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D02BOW
|
|||
| Former ID |
DIB020314
|
|||
| Drug Name |
McN-A-343
|
|||
| Synonyms |
McN-A-343; 55-45-8; MCN A-343 chloride; McN-A 343; MCN A-343; UNII-CW55R761RE; (4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium chloride; CW55R761RE; A 343; 4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium Chloride; 2-Butyn-1-aminium, 4-((((3-chlorophenyl)amino)carbonyl)oxy)-N,N,N-trimethyl-, chloride; Carbanilic acid, m-chloro-, ester with (4-hydroxy-2-butynyl)trimethylammonium chloride; Butyl-1-aminium, 4-((((3-chlorophenyl)amino)carbonyl)oxy)-N,N,N-trimethyl-, chloride
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL
|
||
| Formula |
C14H18Cl2N2O2
|
|||
| Canonical SMILES |
C[N+](C)(C)CC#CCOC(=O)NC1=CC(=CC=C1)Cl.[Cl-]
|
|||
| InChI |
1S/C14H17ClN2O2.ClH/c1-17(2,3)9-4-5-10-19-14(18)16-13-8-6-7-12(15)11-13;/h6-8,11H,9-10H2,1-3H3;1H
|
|||
| InChIKey |
CXFZFEJJLNLOTA-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 55-45-8
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID |
7979865, 8153674, 14874555, 17404840, 29224951, 46500418, 49868158, 50106034, 53777383, 57323054, 79034981, 92303548, 99029911, 103136848, 103273027, 104310635, 117371041, 121360960, 124801325, 125541004, 134222881, 134972116, 135650571, 135697844, 137231119, 162226357, 163564231, 175612335, 178126905, 179293821, 198959015, 229036075, 241097765, 241182383, 241375396
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | International Union of Basic and Clinical Pharmacology. XC. multisite pharmacology: recommendations for the nomenclature of receptor allosterism and allosteric ligands. Pharmacol Rev. 2014 Oct;66(4):918-47. | |||
| REF 2 | Pharmacological characterization of the M1 muscarinic receptors expressed in murine fibroblast B82 cells. J Pharmacol Exp Ther. 1989 Feb;248(2):661-70. | |||
| REF 3 | Human muscarinic receptors expressed in A9L and CHO cells: activation by full and partial agonists. Br J Pharmacol. 1995 Mar;114(6):1241-9. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.